AxoGen (AXGN) Piper Sandler 37th Annual Healthcare Conference summary

Mission and market opportunity

• Focused on establishing restoration of peripheral nerve function as a standard of care, addressing a large, underpenetrated market in extremities, breast, OMF, head and neck, and prostate.

• Nerve injuries are significantly undertreated due to lack of awareness, clinical guidelines, and training.

• Current business is domestic but plans to expand globally, recognizing nerve injuries as a worldwide health issue.

Product innovation and clinical approach

• Developed a unique allograft product (Avance) and a portfolio of connection, protection, and termination devices for nerve repair.

• Emphasizes a favorable benefit-risk profile, with minimal added risk to patients.

• Ongoing investment in next-generation products and easier nerve coaptation techniques.

Strategic priorities and growth plans

• Strategic plan targets 15%-20% annual growth, improved gross margins, and funding operations through organic cash flow.

• Focus areas include extremities (trauma), breast, OMF/head and neck, and prostate, with tailored approaches for each.

• Expanding commercial team and new product development to sustain growth.